Remdesivir, Renal Function and Short-Term Clinical Outcomes in Elderly COVID-19 Pneumonia Patients: A Single-Centre Study.

Edoardo BiancalanaMartina ChiriacòPaolo SciarroneAlessandro MengozziSandra MechelliStefano TaddeiAnna Solini

Published in: Clinical interventions in aging (2021)

We show here for the first time as remdesivir does not influence eGFR in a cohort of elderly people hospitalized for SARS CoV2, and that eGFR gain during such treatment is coupled with a better prognosis.

Keyphrases

sars cov
small cell lung cancer
end stage renal disease
epidermal growth factor receptor
tyrosine kinase
coronavirus disease
ejection fraction
newly diagnosed
chronic kidney disease
respiratory syndrome coronavirus
prognostic factors
middle aged
patient reported
smoking cessation
replacement therapy